247 related articles for article (PubMed ID: 31243671)
1. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent.
Semkina AS; Abakumov MA; Grinenko NF; Lipengolts AA; Nukolova NV; Chekhonin VP
Bull Exp Biol Med; 2017 Apr; 162(6):808-811. PubMed ID: 28429228
[TBL] [Abstract][Full Text] [Related]
3. Iron oxide nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of brain tumors.
Richard S; Boucher M; Lalatonne Y; Mériaux S; Motte L
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1515-1520. PubMed ID: 28017683
[TBL] [Abstract][Full Text] [Related]
4. Pheomelanin-coated iron oxide magnetic nanoparticles: a promising candidate for negative T2 contrast enhancement in magnetic resonance imaging.
Zottis AD; Beltrame JM; Lara LR; Costa TG; Feldhaus MJ; Pedrosa RC; Ourique F; de Campos CE; Isoppo Ede A; da Silva Miranda F; Szpoganicz B
Chem Commun (Camb); 2015 Jun; 51(56):11194-7. PubMed ID: 26073290
[TBL] [Abstract][Full Text] [Related]
5. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
[TBL] [Abstract][Full Text] [Related]
6. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging.
Medarova Z; Balcioglu M; Yigit MV
Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Dobrodumov AV; Zhakhov AV; Mikhrina AL; Pitkin E; Parr MA; Rolich VI; Simbircev AS; Ischenko AM
Neoplasia; 2015 Jan; 17(1):32-42. PubMed ID: 25622897
[TBL] [Abstract][Full Text] [Related]
9. In vitro MRI of biodegradable hybrid (iron oxide/polycaprolactone) magnetic nanoparticles prepared via modified double emulsion evaporation mechanism.
Ahmed N; Ahmad NM; Fessi H; Elaissari A
Colloids Surf B Biointerfaces; 2015 Jun; 130():264-71. PubMed ID: 25960142
[TBL] [Abstract][Full Text] [Related]
10. Relaxation Properties of Contrast Media for MRI Based on Iron Oxide Nanoparticles in Different Magnetic Fields.
Chekhonin VP; Abakumov MA; Mazhuga AG; Bagdinova AN; Demikhov EI; Demikhov TE; Mishkinis BY; Konstantinov MV; Tarasov VP; Shumm BA; Gippius AA; Gervits NV; Shumm AB
Bull Exp Biol Med; 2019 May; 167(1):97-99. PubMed ID: 31183644
[TBL] [Abstract][Full Text] [Related]
11. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
[TBL] [Abstract][Full Text] [Related]
12. VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor.
Abakumov MA; Nukolova NV; Sokolsky-Papkov M; Shein SA; Sandalova TO; Vishwasrao HM; Grinenko NF; Gubsky IL; Abakumov AM; Kabanov AV; Chekhonin VP
Nanomedicine; 2015 May; 11(4):825-33. PubMed ID: 25652902
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line.
Ulanova M; Gloag L; Kim CK; Bongers A; Kim Duong HT; Gooding JJ; Tilley RD; Sachdev PS; Braidy N
Nanomedicine (Lond); 2024 Feb; 19(4):303-323. PubMed ID: 38270934
[TBL] [Abstract][Full Text] [Related]
14. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
[TBL] [Abstract][Full Text] [Related]
15. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
16. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
17. Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies.
Nedyalkova M; Donkova B; Romanova J; Tzvetkov G; Madurga S; Simeonov V
Adv Colloid Interface Sci; 2017 Nov; 249():192-212. PubMed ID: 28499604
[TBL] [Abstract][Full Text] [Related]
18. Functionalised iron oxide nanoparticles for multimodal optoacoustic and magnetic resonance imaging.
Bell G; Balasundaram G; Attia ABE; Mandino F; Olivo M; Parkin IP
J Mater Chem B; 2019 Apr; 7(13):2212-2219. PubMed ID: 32073580
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic Fe3O4 Nanoparticles: Synthesis by Thermal Decomposition of Iron(III) Glucuronate and Application in Magnetic Resonance Imaging.
Patsula V; Kosinová L; Lovrić M; Ferhatovic Hamzić L; Rabyk M; Konefal R; Paruzel A; Šlouf M; Herynek V; Gajović S; Horák D
ACS Appl Mater Interfaces; 2016 Mar; 8(11):7238-47. PubMed ID: 26928653
[TBL] [Abstract][Full Text] [Related]
20. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
Shanavas A; Sasidharan S; Bahadur D; Srivastava R
J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
